- Home
- MRK vs C Comparison
MRK vs C Comparison
Compare MRK & C Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRK | C |
|---|---|---|
| Founded | 2000 | 1812 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.7B | 193.7B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | MRK | C |
|---|---|---|
| Price | $120.03 | $125.97 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 16 |
| Target Price | $124.38 | ★ $127.88 |
| AVG Volume (30 Days) | 6.7M | ★ 10.5M |
| Earning Date | 04-30-2026 | 04-14-2026 |
| Dividend Yield | ★ 2.80% | 1.93% |
| EPS Growth | ★ 8.01 | N/A |
| EPS | ★ 7.28 | N/A |
| Revenue | ★ $65,011,000,000.00 | N/A |
| Revenue This Year | $3.73 | $22.84 |
| Revenue Next Year | $5.42 | $3.89 |
| P/E Ratio | $16.69 | ★ $16.63 |
| Revenue Growth | ★ 1.31 | N/A |
| 52 Week Low | $75.40 | $61.30 |
| 52 Week High | $125.14 | $125.48 |
Technical Indicators
Market Signals| Indicator | MRK | C |
|---|---|---|
| Relative Strength Index (RSI) | 52.37 | 70.20 |
| Support Level | $113.27 | $92.68 |
| Resistance Level | $125.14 | N/A |
| Average True Range (ATR) | 2.72 | 3.30 |
| MACD | 0.23 | 1.68 |
| Stochastic Oscillator | 58.52 | 98.42 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About C Citigroup Inc.
Citigroup is a global financial-services company doing business in more than 160 countries and jurisdictions. Citigroup's operations are organized into five primary segments: services, markets, banking, US personal banking, and wealth management. The bank's primary services include cross-border banking needs for multinational corporates, investment banking and trading, and credit card services in the United States.